KEGG: sha:SH0928
STRING: 279808.SH0928
ATP synthase subunit b (atpF) in S. haemolyticus is a critical component of the bacterial F-type ATP synthase, which is essential for energy metabolism. The protein functions as part of the F₀ sector of the ATP synthase complex, which is embedded in the cell membrane. This subunit plays a crucial role in the structural integrity of the ATP synthase complex and contributes to the proton translocation mechanism necessary for ATP production.
In S. haemolyticus, which is a significant nosocomial pathogen frequently isolated from bloodstream and medical device-related infections, ATP synthase is particularly important for survival and pathogenicity in the hospital environment . Unlike some bacteria that can survive without functional ATP synthase, members of the Bacillales order (including Staphylococcus species) require ATP synthase not only for ATP production but also potentially for pH homeostasis, making it a potential target for antimicrobial development .
The atpF gene in S. haemolyticus is located within the ATP synthase operon. Based on genomic analysis of S. haemolyticus strains, the ATP synthase genes are typically found outside the oriC environ region, which is significant because this positioning affects the stability of the gene during replication and potentially during genomic rearrangements.
Unlike some regions of the S. haemolyticus genome that show high instability and frequent large-scale genomic deletions (particularly within the oriC environ), the ATP synthase operon tends to be more conserved . This conservation highlights the essential nature of the ATP synthase complex for bacterial survival. The atpF gene encodes the 176-amino acid ATP synthase subunit b protein that contributes to the stator portion of the ATP synthase complex .
For the recombinant production of S. haemolyticus ATP synthase subunit b, E. coli expression systems have proven most effective. The commercially available recombinant protein utilizes E. coli as the expression host for the full-length (1-176 amino acids) protein with an N-terminal His-tag .
When designing an expression system for atpF, researchers should consider:
Vector selection: pET-based expression vectors under the control of T7 promoter are commonly used, similar to other membrane protein expression systems. Alternatively, the pMAL expression system has been successful for expressing ATP synthase subunits from other organisms .
E. coli strain: BL21(DE3) or T7 Express lysY/Iq strains are recommended for expressing potentially toxic membrane proteins .
Co-expression with chaperones: For improved yields, co-transformation with vectors expressing chaperone proteins such as DnaK, DnaJ, and GrpE (e.g., pOFXT7KJE3 plasmid) can substantially increase quantities of recombinant proteins that are difficult to produce .
Induction conditions: Optimizing IPTG concentration, temperature, and induction time is critical for maximizing protein yield while maintaining proper folding.
The purification of recombinant S. haemolyticus ATP synthase subunit b typically employs a multi-step approach:
Immobilized Metal Affinity Chromatography (IMAC): For His-tagged recombinant atpF, Ni-NTA chromatography is the primary purification method. This involves:
Secondary purification: Additional purification steps may include:
Size exclusion chromatography to remove aggregates and isolate properly folded protein
Ion exchange chromatography to further separate the target protein from contaminants
Storage considerations: The purified protein is typically stored in Tris/PBS-based buffer with 6% trehalose at pH 8.0 to maintain stability. For long-term storage, adding glycerol (final concentration 5-50%) and storing at -20°C/-80°C in aliquots is recommended to avoid repeated freeze-thaw cycles .
Recombinant atpF can be utilized to investigate potential inhibitors of S. haemolyticus ATP synthase through several experimental approaches:
Inverted membrane vesicle assays: Purified recombinant atpF can be reconstituted with other ATP synthase subunits to form functional complexes in inverted membrane vesicles. These preparations can be used for ATP synthesis assays where the IC₅₀ values of various compounds can be determined. This approach was successfully used to identify tomatidine as an inhibitor of S. aureus ATP synthase, with potential applications for other Staphylococcal species .
Binding studies: Direct binding assays between recombinant atpF and potential inhibitors can be performed using techniques such as:
Surface plasmon resonance (SPR)
Isothermal titration calorimetry (ITC)
Fluorescence-based binding assays
Structural studies: Recombinant atpF can be used for structural characterization to identify potential binding sites for inhibitors. As demonstrated with ATP synthase subunit C, understanding the structural features can reveal how mutations affect inhibitor binding and suggest molecular mechanisms of resistance .
The selectivity index (SI) of potential inhibitors should be calculated by comparing IC₅₀ values between bacterial ATP synthase and mammalian mitochondrial ATP synthase to ensure therapeutic potential. For example, tomatidine analogs demonstrated SI values >10⁵ for S. aureus ATP synthase versus mitochondrial ATP synthase .
Site-directed mutagenesis of recombinant S. haemolyticus atpF can provide valuable insights into the structure-function relationship of ATP synthase:
Identification of critical residues: By systematically mutating conserved amino acids in atpF, researchers can identify residues essential for:
Subunit-subunit interactions within the ATP synthase complex
Stator formation and function
Proton translocation or coupling to the rotary mechanism
Experimental approach:
Generate atpF variants using PCR-based site-directed mutagenesis
Express and purify the mutant proteins using the same protocol as for wild-type
Assess the ability of mutants to complement ATP synthase function in reconstitution experiments
Measure ATP synthesis/hydrolysis rates of the reconstituted complexes
Analyze effects on protein-protein interactions using techniques like pull-down assays or crosslinking studies
Resistance studies: Similar to the approach used for ATP synthase subunit C in S. aureus, researchers can identify mutations in atpF that confer resistance to specific inhibitors. These mutations can reveal the binding sites and mechanisms of inhibitor action .
Low yields of recombinant S. haemolyticus atpF protein can be attributed to several factors, with specific solutions:
Protein toxicity to host cells:
Protein misfolding and aggregation:
Optimize solubilization conditions with different detergents
Include stabilizing agents like glycerol or specific lipids in lysis buffers
Consider fusion tags that enhance solubility (MBP, SUMO, etc.)
Protein degradation:
Include a cocktail of protease inhibitors during purification
Reduce purification time by optimizing protocols
Maintain samples at 4°C throughout the purification process
Expression optimization:
Screen multiple E. coli strains (BL21, C41, C43 for membrane proteins)
Test different growth media (LB, TB, 2xYT)
Optimize cell density at induction (typically OD₆₀₀ of 0.6-0.8)
Statistical analysis of optimization experiments should follow a factorial design approach to identify significant factors affecting protein yield and potential interactions between factors .
Verifying proper folding and functionality of purified recombinant S. haemolyticus atpF involves multiple complementary techniques:
Structural assessment:
Circular dichroism (CD) spectroscopy to analyze secondary structure elements
Thermal shift assays to assess protein stability
Size exclusion chromatography to detect proper oligomeric state or aggregation
Functional assays:
Reconstitution with other ATP synthase subunits and measurement of ATP synthesis
Binding assays with known interaction partners (other ATP synthase subunits)
ATP hydrolysis assays of reconstituted complexes
Protein-protein interaction studies:
Pull-down assays to confirm interaction with other subunits of the ATP synthase complex
Surface plasmon resonance (SPR) to measure binding kinetics
Crosslinking studies followed by mass spectrometry to identify interaction interfaces
Statistical analysis of functionality:
Studying interactions between recombinant S. haemolyticus atpF and other ATP synthase subunits requires sophisticated experimental approaches:
Co-expression and co-purification:
Design constructs for co-expression of atpF with other subunits in E. coli
Use different affinity tags on different subunits to facilitate co-purification
Analyze the composition of purified complexes by SDS-PAGE and Western blotting
Reconstitution experiments:
Purify individual recombinant subunits separately
Combine purified subunits under conditions favoring complex formation
Verify complex formation by size exclusion chromatography or analytical ultracentrifugation
Assess functionality of reconstituted complexes through ATP synthesis/hydrolysis assays
Structural biology approaches:
X-ray crystallography of co-purified complexes
Cryo-electron microscopy (cryo-EM) of reconstituted ATP synthase complexes
Nuclear magnetic resonance (NMR) studies of specific interactions between subunits
Crosslinking studies:
Use chemical crosslinkers to stabilize transient interactions
Identify crosslinked residues by mass spectrometry
Map interaction interfaces based on crosslinking data
Fluorescence-based interaction studies:
Label purified atpF and other subunits with fluorophores
Measure interactions by fluorescence resonance energy transfer (FRET)
Use fluorescence correlation spectroscopy (FCS) to study interaction dynamics
These experimental approaches should be designed using rigorous statistical considerations, including appropriate controls, replication, and randomization to ensure reliable and reproducible results .